Clinical trial NCT00604253 - References

Diabetes Mellitus, Type 2 — Efficacy and Safety of Insulin Detemir in Type 2 Diabetes Inadequately Controlled on OHA Therapy Alone

Citation(s)

•   Kobayashi M, Iwamoto Y, Kaku K, Kawamori R, Tajima N
  36-week Randomized Multicenter Open-label Parallel Group Phase 3 Trial to Compare Insulin Detemir and NPH Insulin Efficacy and Safety in Once Daily Treatment as an Add-on Current Oral Hypoglycemic Agen
•   Tajima N, Iwamoto Y, Kaku K, Kawamori R, Nishida T, Kobayashi M
  Once-daily insulin detemir added to oral antidiabetic drugs results in less weight gain and a trend for reduced hypoglycaemia in comparison with NPH insulin in Japanese patients with type 2

Comparison of Efficacy and the Safety of Insulin Detemir and Insulin NPH as add-on to Current OHA Therapy in Subjects With type2 Diabetes Mellitus

Details for clinical trial NCT00604253